A 28-year-old cisgender woman who is pregnant tests positive for HIV on a screening test done in the first trimester of pregnancy. She is urgently referred to initiate antiretroviral therapy. Initial laboratory studies show a CD4 count of 718 cells/mm3, an HIV RNA level of 31,510 copies/mL, and a negative HLA-B*5701 test. She has not previously received long-acting injectable cabotegravir. Genotypic drug resistance testing has been ordered and results are pending.
Which one of the following would be considered a preferred antiretroviral regimen for use during pregnancy?
Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Since you are not signed in, your progress won't be saved.
Question Last Updated
June 7th, 2024
June 7th, 2024
Steps to Acquire CE for this Question Bank Topic:
1
Answer
Answer all questions
2
Score 80%+
Answer correctly
3
Claim CE
Choose CNE or CME
4
Give Feedback
Complete survey
5